Last updated on May 2019

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS


Brief description of study

This study will evaluate whether prolonged oral levosimendan can preserve respiratory function more effectively than placebo, resulting in better patient functionality as measured by the ALSFRS-R scale. In this randomized, double-blind, placebo-controlled, parallel-group, multicenter study, subjects are allocated in a 2:1 ratio to receive either levosimendan (1 -2 mg daily) or placebo for 48 weeks. The primary endpoint is slow vital capacity (SVC) at 12 weeks, with the impact on patient function assessed through 48 weeks, adjusted for patient outcome, using ALSFRS-R (combined assessment of function and survival, CAFS). Other important efficacy measures include time to respiratory events, clinical global impression (CGI), assessment of dyspnea using the Borg scale and sleep scales (Pittsburgh sleep quality index and Epworth sleepiness scale). Patient safety is monitored using conventional methods including adverse events, safety laboratory tests, vital signs and 12-lead EKG. Following screening and baseline visits, patients attend the clinic at 2, 4, 8, 12, 24, 36 and 48 weeks, with telephone assessments conducted at weeks 18, 30 and 42. An end of study visit is performed 14-25 days after the last study treatment administration. The study will be monitored by an independent data and safety monitoring board. A long-term extension study will be available for patients completing the study.

Clinical Study Identifier: NCT03505021

Find a site near you

Start Over

Neurology Associates

Lincoln, NE United States
  Connect »

Hospital for Special Care

New Britain, CT United States
  Connect »

The Ohio State University

Columbus, OH United States
  Connect »

Cedars-Sinai Medical Center

Los Angeles, CA United States
  Connect »

California Pacific Medical Center

San Francisco, CA United States
  Connect »

Colorado Springs Neurological Associates

Colorado Springs, CO United States
  Connect »

Georgetown University

Washington, WA United States
  Connect »

Providence Holy Cross Medical Center

Fort Lauderdale, FL United States
  Connect »

University of Florida

Gainesville, FL United States
  Connect »

Mayo Clinic - Jacksonville

Jacksonville, FL United States
  Connect »

Augusta University

Augusta, GA United States
  Connect »

University of Chicago

Chicago, IL United States
  Connect »

Kentucky Neuroscience Research

Louisville, KY United States
  Connect »

The Johns Hopkins Hospital

Baltimore, MD United States
  Connect »

University of Michigan

Ann Arbor, MI United States
  Connect »

Mayo Clinic - Rochester

Rochester, MN United States
  Connect »

HealthPartners Specialty Center

Saint Paul, MN United States
  Connect »

Mount Sinai Beth Israel

New York, NY United States
  Connect »

Hospital for Special Surgery

New York, NY United States
  Connect »

Allegheny General Hospital

Pittsburgh, PA United States
  Connect »

Texas Neurology

Dallas, TX United States
  Connect »

Froedtert Hospital

Milwaukee, WI United States
  Connect »

Brain and Mind Centre

Camperdown, Australia
  Connect »

Flinders Medical Centre

Bedford Park, Australia
  Connect »

Barts Health NHS Trust

London, United Kingdom
  Connect »